45 Chinese companies at Pharma Asia 2026: APIs, packaging and machinery
China is the largest international presence in the 2026 exhibitor list. Why that matters for an industry that imports most of its raw materials.

In this article
Of the companies on the 2026 Pharma Asia exhibitor list, 45 are from China — by far the largest group from outside Pakistan. Eighteen of them are in Hall 3, with others in Halls 1, 2, 4, 5 and 6.
Who is coming
The names show the range: pharmaceutical producers such as Zhejiang Jingxin Pharmaceutical, Reyoung Pharmaceutical, Apeloa Pharmaceutical and Hebei Huachen Pharmaceutical Group; chemical suppliers such as Shanghai Hope-Chem and Anhui Chico Chemical; packaging material makers such as Hebei Kaicheng Packaging and Henan Roshn Packaging Material; and machinery builders including Truking Technology, Tofflon Science & Technology Group, Changzhou Haijiang Drying Equipment and Qingdao Feifan Packaging Machinery.
Why the link matters
Pakistan makes nearly 85% of its finished medicines at home but still imports almost 90% of its active pharmaceutical ingredients and other raw materials, Federal Health Minister Mustafa Kamal said at the Pakistan-China Pharmaceutical & Healthcare B2B Investment Conference in Islamabad in July 2026. That conference, organised by SIFC, the health ministry and DRAP, brought about 160 Chinese pharmaceutical companies together with around 340 Pakistani firms.
A December 2025 IPRI policy paper found that China supplied 58.6% of Pakistan’s pharmaceutical imports in FY24, ahead of India at 13.5%.
What Chinese suppliers offer
China’s pharmaceutical industry is one of the largest in the world, and its exporters cover almost every part of the supply chain that Pakistani manufacturers use:
| Area | Examples on the 2026 list |
|---|---|
| APIs and finished pharmaceuticals | Zhejiang Jingxin, Reyoung, Apeloa, Hebei Huachen |
| Chemicals and intermediates | Shanghai Hope-Chem, Anhui Chico Chemical |
| Packaging materials | Hebei Kaicheng Packaging, Henan Roshn Packaging Material |
| Machinery and process equipment | Truking, Tofflon, Changzhou Haijiang Drying Equipment, Qingdao Feifan Packaging Machinery |
Chinese machinery makers have moved steadily up the value chain, from basic equipment to complete lines for oral solid dosage, liquids and sterile products, including freeze-drying and aseptic filling. For many Pakistani plants they offer a combination of price, delivery time and capability that is hard to match.
Making the most of the meeting
- Prepare your requirements. Bring product lists, specifications or line requirements so suppliers can respond with concrete offers.
- Ask about registration support. For APIs, check what documentation the supplier can provide for registration with DRAP and export markets.
- Ask about local support. For machinery, check who installs, trains and services in Pakistan, and where spare parts are held.
- Talk to their local partners. Many Chinese companies work through Pakistani agents and distributors, who handle imports, documentation and after-sales service.
- Plan quality checks. Agree on samples, audits and quality agreements before placing large orders — see what buyers should know.
Beyond buying and selling
The July 2026 investment conference showed that the relationship is moving from trade towards investment: joint ventures, technology transfer and local production of raw materials, vaccines and devices. Pharma Asia gives companies on both sides a chance to continue those conversations face to face, a few months after the agreements were signed.
Language and documents
Practical details smooth the way: confirming who on the stand speaks for technical and commercial questions, asking for documentation in English, and agreeing in writing on specifications, delivery terms and quality responsibilities. Local agents can help bridge language and time-zone gaps after the show.
What this means for buyers
- Pharma Asia lets Pakistani manufacturers meet Chinese API, excipient and packaging suppliers face to face, alongside local importers and distributors.
- Localising API production is now an explicit government aim, so joint ventures and technology transfer are likely topics on the show floor. Read more in our article on API dependence.
The full list is on the exhibitors page.
Sources
- Pharma Asia, Exhibitor List 2026 (organiser’s document)
- Dental Tribune Pakistan, “Pakistan, China launch major pharma investment drive to boost local manufacturing”, 17 July 2026
- Islamabad Policy Research Institute, policy paper on Pakistan’s pharmaceutical sector (Dr Aneel Salman and Sheraz Ahmad Choudhary), December 2025


